Stock listing
Lang & Schwarz:A2PX00 BICO Group AB Aktie
German listing (Lang & Schwarz) of BICO Group AB · home listing Stockholm:BICO
Follow BICO Group AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:BICO
15.18 SEK -1.12 (-6.9%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:BICO
- Day range
- 15.16 – 15.78 SEKNov 20, 2026
- Volume
- 321,047 sharesNov 20, 2026
- Market cap
- 1.05B SEKAt the close on Nov 20, 2026 · price × 69.07M shares outstanding
- 52-week range
- 12.94 – 25.40 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 7.81M SEKMedian day 213,580 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:BICO · Home | 15.18 SEK | -1.12 (-6.9%) | 321,047 | 15.78 | 15.78 | 15.16 | 16.30 | Close on Nov 20, 2026 |
| Frankfurt:49Z | €1.374 EUR | -0.082 (-5.6%) | 1,500 | €1.40 | €1.406 | €1.374 | €1.456 | Close on Nov 20, 2026 |
| OTC:CLLKF | $1.471 USD | -1.071 (-42.1%) | 320 | $1.471 | $1.471 | $1.471 | $2.543 | Close on Nov 20, 2026 |
| Dusseldorf:49Z | €1.306 EUR | -0.106 (-7.5%) | — | €1.40 | €1.40 | €1.306 | €1.412 | Close on Nov 20, 2026 |
| OTC:BCCOY | $0.46 USD | -0.017 (-3.6%) | 200 | $0.46 | $0.46 | $0.46 | $0.477 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:BICO · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 15.18 | -1.12 | -6.9% | 15.78 | 15.78 | 15.16 | 321,047 | |
| 16.30 | +0.72 | +4.6% | 15.54 | 16.58 | 15.54 | 435,930 | |
| 15.58 | 0.00 | 0.0% | 15.08 | 16.06 | 15.08 | 904,506 | |
| 15.58 | -1.12 | -6.7% | 16.70 | 16.70 | 15.16 | 1,446,258 | |
| 16.70 | +0.06 | +0.4% | 16.62 | 17.30 | 16.22 | 625,135 | |
| 16.64 | -0.12 | -0.7% | 17.30 | 18.08 | 16.36 | 1,928,119 | |
| 16.76 | -7.94 | -32.1% | 25.05 | 25.05 | 16.68 | 6,230,998 | |
| 24.70 | +0.95 | +4.0% | 24.05 | 25.25 | 24.05 | 227,753 | |
| 23.75 | -0.60 | -2.5% | 24.35 | 24.85 | 23.60 | 177,653 | |
| 24.35 | -0.25 | -1.0% | 24.25 | 24.85 | 23.70 | 107,532 | |
| 24.60 | +0.45 | +1.9% | 24.15 | 25.40 | 24.05 | 242,936 | |
| 24.15 | +0.65 | +2.8% | 23.45 | 24.25 | 23.45 | 125,777 | |
| 23.50 | -0.60 | -2.5% | 23.85 | 23.85 | 22.05 | 367,677 | |
| 24.10 | -0.35 | -1.4% | 24.40 | 24.40 | 23.75 | 81,669 | |
| 24.45 | +0.30 | +1.2% | 24.50 | 24.70 | 23.95 | 91,295 | |
| 24.15 | -0.10 | -0.4% | 24.35 | 24.45 | 23.95 | 81,869 | |
| 24.25 | +0.10 | +0.4% | 24.20 | 24.95 | 24.05 | 92,193 | |
| 24.15 | +0.10 | +0.4% | 24.00 | 24.40 | 23.80 | 75,823 | |
| 24.05 | 0.00 | 0.0% | 23.70 | 24.65 | 23.70 | 74,171 | |
| 24.05 | +0.20 | +0.8% | 23.90 | 24.60 | 23.70 | 110,699 | |
| 23.85 | -0.15 | -0.6% | 23.75 | 24.60 | 23.70 | 159,583 | |
| 24.00 | +0.30 | +1.3% | 23.70 | 24.30 | 23.50 | 112,391 | |
| 23.70 | -0.40 | -1.7% | 24.20 | 24.35 | 23.55 | 188,611 | |
| 24.10 | -0.15 | -0.6% | 24.30 | 24.45 | 23.70 | 235,880 | |
| 24.25 | -0.30 | -1.2% | 24.20 | 25.35 | 24.20 | 400,366 | |
| 24.55 | -0.35 | -1.4% | 24.15 | 25.00 | 24.15 | 176,434 | |
| 24.90 | 0.00 | 0.0% | 25.05 | 25.35 | 24.80 | 282,181 | |
| 24.90 | +1.00 | +4.2% | 24.00 | 25.20 | 23.90 | 279,435 | |
| 23.90 | +0.20 | +0.8% | 23.75 | 24.40 | 23.75 | 341,697 | |
| 23.70 | +1.75 | +8.0% | 21.40 | 24.00 | 21.40 | 654,086 | |
| 21.95 | +0.20 | +0.9% | 21.60 | 21.95 | 21.10 | 197,562 | |
| 21.75 | -0.05 | -0.2% | 21.80 | 22.15 | 21.35 | 140,491 | |
| 21.80 | -0.25 | -1.1% | 22.00 | 23.20 | 21.70 | 459,005 | |
| 22.05 | -0.40 | -1.8% | 22.60 | 22.60 | 21.95 | 147,462 | |
| 22.45 | +0.90 | +4.2% | 21.50 | 22.65 | 21.05 | 382,991 | |
| 21.55 | -0.30 | -1.4% | 21.80 | 22.00 | 21.05 | 184,295 | |
| 21.85 | +0.60 | +2.8% | 21.25 | 22.15 | 21.15 | 253,458 | |
| 21.25 | -0.55 | -2.5% | 22.35 | 22.50 | 21.25 | 233,877 | |
| 21.80 | -0.45 | -2.0% | 22.25 | 22.45 | 21.70 | 131,783 | |
| 22.25 | -0.15 | -0.7% | 22.35 | 22.90 | 21.95 | 176,158 | |
| 22.40 | -0.10 | -0.4% | 22.50 | 22.65 | 22.10 | 91,884 | |
| 22.50 | +0.10 | +0.4% | 22.45 | 22.85 | 22.10 | 120,681 | |
| 22.40 | +0.50 | +2.3% | 21.75 | 22.60 | 21.55 | 167,112 | |
| 21.90 | -0.35 | -1.6% | 22.30 | 22.70 | 21.90 | 167,981 | |
| 22.25 | -0.35 | -1.5% | 22.65 | 22.95 | 22.05 | 217,817 | |
| 22.60 | +0.85 | +3.9% | 21.75 | 22.95 | 21.75 | 167,009 | |
| 21.75 | +1.30 | +6.4% | 20.45 | 21.95 | 20.45 | 248,814 | |
| 20.45 | -0.05 | -0.2% | 20.50 | 21.10 | 20.25 | 171,484 | |
| 20.50 | +0.05 | +0.2% | 20.40 | 20.90 | 20.10 | 147,358 | |
| 20.45 | -0.15 | -0.7% | 20.60 | 21.10 | 20.45 | 102,066 | |
| 20.60 | -0.45 | -2.1% | 21.50 | 21.50 | 20.60 | 140,764 | |
| 21.05 | -0.10 | -0.5% | 21.30 | 21.65 | 20.85 | 178,211 | |
| 21.15 | -1.00 | -4.5% | 21.95 | 21.95 | 21.05 | 209,342 | |
| 22.15 | +0.20 | +0.9% | 22.05 | 23.15 | 22.00 | 295,316 | |
| 21.95 | -0.25 | -1.1% | 22.20 | 22.50 | 21.55 | 177,372 | |
| 22.20 | -0.20 | -0.9% | 22.95 | 23.00 | 22.10 | 168,272 | |
| 22.40 | +0.10 | +0.4% | 22.35 | 22.95 | 21.55 | 319,959 | |
| 22.30 | +0.45 | +2.1% | 21.85 | 22.60 | 21.75 | 276,013 | |
| 21.85 | +0.70 | +3.3% | 21.20 | 22.10 | 20.85 | 312,982 | |
| 21.15 | +1.21 | +6.1% | 19.96 | 21.40 | 19.96 | 423,348 | |
| 19.94 | +0.04 | +0.2% | 20.10 | 20.10 | 19.18 | 350,161 | |
| 19.90 | -0.02 | -0.1% | 19.90 | 20.35 | 19.48 | 531,961 | |
| 19.92 | -0.23 | -1.1% | 20.30 | 20.45 | 19.66 | 480,351 | |
| 20.15 | +0.17 | +0.9% | 19.98 | 21.00 | 19.36 | 668,160 | |
| 19.98 | +0.70 | +3.6% | 19.30 | 20.00 | 18.30 | 657,507 | |
| 19.28 | +0.40 | +2.1% | 19.00 | 19.80 | 18.90 | 676,301 |
Splits
1 split · OMXSTO:BICO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 4-for-1 | Split |
- Ticker
- Lang & Schwarz:A2PX00
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Aug 19, 2026
Publication of BICO Group AB: Interim Report Q2 2026
Latest earnings call · Aug 19, 2026
BICO Group (Stockholm:BICO) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Nov 11, 2026
Q3 2026 Earnings Presentation
Earnings · 29 slides
Latest news
Publication of BICO Group AB: Interim Report Q2 2026
Aug 19, 2026
Closed 18.88 (+13.2%) on Aug 19, 2026
Anders Fogelberg appointed President and CEO of BICO Group AB
Aug 18, 2026
Closed 18.88 (+13.2%) on Aug 19, 2026
BICO's Board of Directors has appointed Erik Gatenholm as Board Chair
Jul 31, 2026
Closed 14.90 (+3.5%) on Aug 3, 2026
Changes to the Board of Directors and notice of Extraordinary General Meeting
Jul 6, 2026
Closed 14.90 (-9.5%) on Jul 6, 2026
Bulletin from the Annual General Meeting in BICO Group AB (publ)
May 7, 2026
Closed 19.00 (-3.9%) on May 8, 2026
Interim Report Q1 2026 (Report)
Apr 29, 2026
Closed 20.70 (+10.0%) on Apr 29, 2026
Publication of BICO Group AB: Interim Report Q1 2026
Apr 29, 2026
Closed 20.70 (+10.0%) on Apr 29, 2026
Notice to attend the Annual General Meeting in BICO Group AB (publ)
Apr 1, 2026
Closed 17.75 (+6.4%) on Apr 1, 2026
BICO Publishes Annual and Sustainability Report 2025
Mar 18, 2026
Closed 17.15 (+1.7%) on Mar 18, 2026
BICO Group AB has settled its convertible bonds
Mar 18, 2026
Closed 17.15 (+1.7%) on Mar 18, 2026
BICO Group AB on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 15 in the last 12 months · 15 in all · newest Aug 19, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Aug 19, 2026
- Decks
- 22 decks · latest Nov 11, 2026
Where BICO Group AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:BICO · Home listing | Stockholm | Sweden | SEK |
| Tradegate:49Z | Tradegate | Germany | EUR |
| gettex:49Z | gettex | Germany | EUR |
| Frankfurt:49Z | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2PX00 · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2PX00 | LS Exchange | Germany | EUR |
| OTC:CLLKF | OTC | United States | USD |
| Stuttgart:49Z | Stuttgart | Germany | EUR |
| Dusseldorf:49Z | Dusseldorf | Germany | EUR |
| OTC:BCCOY | OTC | United States | USD |
| Aquis:BICOS | Aquis | United Kingdom | SEK |
| Aquis:BICOS | Aquis | United Kingdom | SEK |
| Turquoise:BICOS | Turquoise | United Kingdom | SEK |
| Hamburg:49Z | Hamburg | Germany | EUR |
| Munich:49Z | Munich | Germany | EUR |
| Hanover:49Z | Hanover | Germany | EUR |
| Xetra:49Z | Xetra | Germany | EUR |
Valuation
EV/sales 0.6× against a median of 1.3×: 2nd lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Aug 31, 2026 · price Nov 20, 2026
- Enterprise value
- 924.2M SEK
- P/E
- Loss
- EV/sales
- 0.6×
- EV/EBITDA
- 2.1×
- Price/book
- 0.8×
- Gross margin
- 52.1%
- Operating margin
- −5.0%
- Net margin
- −28.3%
- Debt to equity
- 0.3×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| BICO Group AB Class B · OMXSTO:BICO | US$102.7M | US$90.50M | n/a | 0.6× | 2.1× | 0.8× | −28.3% | 0.3× | n/a |
| Fine Foods & Pharmaceuticals N.T.M. SpA · MIL:FF | US$123.5M | US$174.6M | 11.1× | 0.6× | 4.6× | 0.8× | 4.0% | 0.6× | n/a |
| Burning Rock Biotech Ltd. · NASDAQ:BNR | US$116.7M | US$60.54M | n/a | 0.8× | n/a | 1.6× | −13.6% | 0.1× | 1.51 |
| BIODYNE Co., Ltd. · KRX:314930 | US$115.0M | US$104.0M | 182× | 19.9× | 70.7× | 3.5× | 12.1% | 0.0× | n/a |
| Photocure ASA · OSL:PHO | US$113.9M | US$97.23M | 22.9× | 1.4× | 6.1× | 1.9× | 7.1% | 0.0× | n/a |
| ArcticZymes Technologies ASA · OSL:AZT | US$108.4M | US$80.84M | 66.1× | 6.2× | 24.6× | 3.0× | 12.7% | 0.0× | n/a |
| NanoenTek, Inc. · KRX:039860 | US$107.8M | US$71.26M | 24.8× | 2.2× | 17.4× | 1.5× | 13.3% | 0.0× | n/a |
| Devyser Diagnostics AB · OMXSTO:DVYSR | US$99.24M | US$94.86M | 39.9× | 3.8× | 17.5× | 2.6× | 10.0% | 0.1× | n/a |
| Quanterix Corporation · NASDAQ:QTRX | US$93.06M | US$47.06M | n/a | 0.3× | n/a | 0.4× | −75.0% | 0.1× | 1.87 |
| Exagen Inc. · NASDAQ:XGN | US$92.10M | US$86.82M | n/a | 1.2× | n/a | 6.7× | −25.1% | 1.7× | 2.52 |
| Biodesix, Inc. · NASDAQ:BDSX | US$83.83M | US$105.4M | n/a | 1.0× | n/a | 9.7× | −25.7% | 5.8× | 1.56 |
| Median of the others | US$108.1M | US$90.84M | 32.3× | 1.3× | 17.5× | 2.3× | 5.5% | 0.1× | 1.72 |
Forecasts
Analysts' consensus from EODHD, read Nov 13, 2026. Not 6ix's view and not investment advice.
- Price target
- 29.50 SEK · Analysts' mean
- EPS, year to Dec 2026
- -1.14 · 1 analyst
- Revenue, year to Dec 2026
- 1.58B · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Anders Fogelberg | President and CEO |
| Jacob Thordenberg | Chief Financial Officer |
| Isabelle Ljunggren | Investor Relations |
| Jesper Hagberg | Chief Operations & Digital Officer |
Board
| Director | Role |
|---|---|
| Erik Gatenholm | Board Chair |
| Christian Wildmoser | Board member |
| Olof Stranding | Board member |
Events
- Next results
- Feb 17, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| BICO Group (Stockholm:BICO) Q2 2026 Earnings Call | Wed, Aug 19, 2026 · 4:00 AM ET | Replay |
| BICO Group (Stockholm:BICO) Q1 2026 Earnings Call | Wed, Apr 29, 2026 · 4:00 AM ET | Replay |
| BICO Group (Stockholm:BICO) Q4 2025 Earnings Call | Wed, Feb 18, 2026 · 4:00 AM ET | Replay |
| BICO Group (Stockholm:BICO) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 4:00 AM ET | Replay |
| BICO Group (Stockholm:BICO) Q2 2025 Earnings Call | Tue, Aug 19, 2025 · 4:00 AM ET | Replay |
| BICO Group (Stockholm:BICO) Q1 2025 Earnings Call | Tue, Apr 29, 2025 · 4:00 AM ET | Replay |
| BICO Group (Stockholm:BICO) Q4 2024 Earnings Call | Wed, Feb 19, 2025 · 4:00 AM ET | Replay |
| BICO Group (Stockholm:BICO) Q3 2024 Earnings Call | Tue, Nov 26, 2024 · 4:00 AM ET | Replay |
| BICO Group (Stockholm:BICO) Q2 2024 Earnings Call | Tue, Aug 20, 2024 · 4:00 AM ET | Replay |
| BICO Group (Stockholm:BICO) Q1 2024 Earnings Call | Tue, May 07, 2024 · 4:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q4 2026 | Nov 11, 2026 · Before open | −32.1% |
| Q3 2026 | Aug 19, 2026 · Before open | +13.2% |
| Q2 2026 | Apr 29, 2026 · Before open | +10.0% |
| Q1 2026 | Feb 18, 2026 · Before open | +12.9% |
| Q4 2025 | Nov 4, 2025 · Before open | +13.8% |
| Q3 2025 | Aug 19, 2025 · Before open | −22.7% |
| Q2 2025 | Apr 29, 2025 · Before open | −6.9% |
| Q1 2025 | Feb 19, 2025 | +10.7% |
| Q4 2024 | Nov 13, 2024 · After close | +0.5% |
| Q3 2024 | Aug 20, 2024 · Before open | −7.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2024 | May 7, 2024 · Before open | −17.4% |
| Q1 2024 | Feb 20, 2024 · Before open | −9.4% |
| Q4 2023 | Nov 14, 2023 · Before open | +13.8% |
| Q3 2023 | Aug 22, 2023 · Before open | −0.9% |
| Q2 2023 | May 4, 2023 · Before open | −8.1% |
| Q1 2023 | Feb 22, 2023 · Before open | −29.4% |
| Q4 2022 | Nov 9, 2022 · Before open | +57.4% |
| Q3 2022 | Aug 24, 2022 · Before open | −0.5% |
| Q2 2022 | May 18, 2022 · Before open | −3.6% |
| Q1 2022 | Feb 23, 2022 · Before open | −9.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 29 slides | Nov 11, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 24 slides | Aug 19, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 31 slides | Apr 29, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 40 slides | Feb 18, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 36 slides | Nov 4, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 26 slides | Aug 19, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 27 slides | Apr 29, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 30 slides | Feb 19, 2025 |
| 43rd Annual J.P. Morgan Healthcare Conference 2025 | Conference | 21 slides | Jan 15, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 35 slides | Nov 26, 2024 |
All 22 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Jefferies Healthcare Conference 2024 | Conference | 21 slides | Nov 21, 2024 |
| Investor Day (September 2024) | Investor day | 100 slides | Sep 17, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 25 slides | Aug 20, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 26 slides | May 7, 2024 |
| JPM Healthcare Conference 2024 | Conference | 27 slides | Jan 10, 2024 |
| Q3 2022 Earnings Presentation | Earnings | 20 slides | Nov 9, 2022 |
| Q2 2022 Earnings Presentation | Earnings | 18 slides | Aug 24, 2022 |
| Merger or Acquisition (December 2021) | Merger or acquisition | 18 slides | Dec 16, 2021 |
| Cellink — Investor Presentation (March 2021) | Investor deck | 29 slides | Mar 10, 2021 |
| Cellink — Investor Day (2021) | Investor day | 98 slides | 2021 |
| Q4 2019/20 Earnings Presentation | Earnings | 31 slides | Oct 22, 2020 |
| Merger or Acquisition (August 2020) | Merger or acquisition | 8 slides | Aug 17, 2020 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Senior secured bonds Closed: €40M raised · DNB Carnegie Dealers: DNB Carnegie (lead) Use of proceeds: General corporate purposes | Jan 28, 2026 | US$47.77M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in SEK
Income statement
| Line | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 | FY2023 | FY2022 | FY2022 | FY2021 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.50B | 1.50B | 1.73B | 1.95B | 2.01B | 2.01B | 2.12B | 2.24B | 1.26B | 1.26B |
| Cost of revenue | 716.9M | 915.3M | 805.1M | 939.0M | 1.02B | 1.02B | 408.9M | 255.0M | ||
| Gross profit | 780.3M | 581.9M | 922.1M | 1.01B | 993.3M | 993.2M | 1.83B | 1.00B | ||
| Research and development | 204.9M | 119.4M | 227.6M | 354.3M | 343.2M | 343.2M | ||||
| Selling, general and administrative | 167.3M | 552.3M | 542.5M | 719.0M | 433.1M | |||||
| Operating income | -1.29B | -252.1M | -301.1M | -289.1M | -566.7M | -566.7M | -274.8M | -618.3M | -236.9M | -160.0M |
| Depreciation and amortization | 217.2M | 478.3M | 460.4M | 1.14B | 289.8M | 940.6M | 191.8M | 191.8M | ||
| EBITDA | -34.9M | 189.2M | -106.3M | 577.5M | 15.0M | 322.3M | -45.1M | 31.8M | ||
| Interest expense | 322.4M | 322.4M | 104.4M | 97.9M | 250.9M | 95.9M | 187.6M | 98.2M | 72.8M | 59.3M |
| Income before tax | -1.58B | -1.58B | -81.3M | -70.6M | -797.3M | -797.3M | -34.9M | -753.1M | -213.4M | -213.4M |
| Income tax | 6.40M | 6.40M | 28.7M | 23.1M | -8.60M | -8.60M | 53.2M | 82.6M | 15.8M | 15.8M |
| Net income | -1.09B | -1.09B | -5.50M | -5.50M | -1.17B | -1.17B | -832.9M | -835.7M | -227.6M | -229.2M |
| Earnings per share, basic | -15.43 | -15.43 | -0.07 | -0.08 | -1,662.00 | -16.62 | -1,294.00 | -12.50 | -3.97 | -3.74 |
| Earnings per share, diluted | -15.43 | -0.07 | -1,662.00 | -1,294.00 | -3.97 |
Balance sheet
| Line | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 | FY2023 | FY2022 | FY2022 | FY2021 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.28B | 1.28B | 946.3M | 598.0M | 861.0M | 804.1M | 925.2M | 925.2M | 481.2M | 481.2M |
| Short-term investments | 993.8M | |||||||||
| Receivables | 376.7M | 429.5M | 450.7M | 488.0M | 520.0M | 577.6M | 699.7M | 1.02B | 576.9M | 797.3M |
| Inventory | 196.4M | 196.4M | 270.5M | 259.0M | 427.3M | 405.2M | 531.0M | 493.1M | 353.5M | 320.6M |
| Current assets | 2.01B | 2.01B | 1.85B | 1.85B | 2.04B | 2.04B | 2.44B | 2.44B | 2.65B | 2.65B |
| Property, plant and equipment | 96.1M | 185.7M | 241.7M | 459.8M | 901.6M | 209.1M | 457.6M | |||
| Goodwill | 775.2M | 2.17B | 2.09B | 5.27B | 5.44B | |||||
| Total assets | 3.70B | 3.70B | 5.48B | 5.48B | 6.06B | 6.06B | 10.2B | 10.2B | 9.75B | 9.75B |
| Accounts payable | 69.6M | 69.6M | 77.9M | 77.9M | 170.2M | 170.2M | 132.6M | 132.6M | 129.1M | 129.1M |
| Current liabilities | 1.57B | 1.57B | 570.8M | 570.8M | 847.0M | 847.0M | 939.5M | 939.5M | 730.5M | 730.5M |
| Long-term debt | 200.0K | 200.0K | 1.34B | 1.34B | 1.42B | 1.42B | 1.38B | 1.38B | 1.35B | 1.35B |
| Total debt | 200.0K | 1.50B | 1.34B | 1.76B | 1.42B | 1.96B | 1.38B | 1.85B | 1.35B | 1.61B |
| Total liabilities | 1.95B | 1.95B | 2.48B | 2.48B | 2.96B | 2.96B | 3.26B | 3.26B | 2.95B | 2.95B |
| Shareholders' equity | 1.75B | 1.75B | 2.98B | 2.98B | 3.07B | 3.07B | 6.91B | 6.91B | 6.77B | 6.77B |
| Shares outstanding | 70.6M | 70.6M | 70.6M | 66.9M | 61.4M |
Cash flow
| Line | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 | FY2023 | FY2022 | FY2022 | FY2021 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 68.4M | 68.4M | 158.4M | 158.4M | 178.4M | 178.4M | -269.4M | -269.4M | -409.2M | -409.2M |
| Capital spending | -13.3M | -13.3M | -44.1M | -85.7M | -171.4M | -291.2M | -274.1M | -529.6M | -110.9M | -267.0M |
| Free cash flow | 55.1M | 55.1M | 114.3M | 72.7M | 7.00M | -112.8M | -543.5M | -799.0M | -520.1M | -676.2M |
| Cash from investing | 709.3M | 709.3M | 128.0M | 128.0M | -129.7M | -129.7M | 212.9M | 212.9M | -4.45B | -4.45B |
| Cash from financing | -455.1M | -455.1M | -200.7M | -200.7M | -102.0M | -102.0M | 455.3M | 455.3M | 4.90B | 4.90B |
| Change in cash | 322.6M | 335.9M | 85.7M | 85.3M | -53.3M | -64.2M | 398.8M | 444.0M | 37.1M | 46.3M |
Cap table
Built by 6ix from BICO Group AB Class B’s releases · as of Jan 28, 2026
- Common shares
- 69,074,895
- Fully diluted
- 69,074,895
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 69,074,895 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 69,074,895 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anders Fogelberg | President and CEO · Since at least Aug 18, 2026 |
| Christian Wildmoser | Board member · Since at least May 7, 2026 |
| Erik Gatenholm | Board Chair · Since at least Jul 31, 2026 |
| Ewa Linsäter | Chief Financial Officer · Dec 10, 2025 – Nov 5, 2026 · Past |
| Isabelle Ljunggren | Investor Relations · Since at least Aug 18, 2026 |
| Jacob Thordenberg | Chief Financial Officer · Since at least Feb 18, 2026 |
| Jesper Hagberg | Chief Operations & Digital Officer · Since at least Dec 16, 2025 |
| Maria Forss | Until Aug 18, 2026 · Past |
| Olof Stranding | Board member · Since at least May 7, 2026 |
| Ryan Bagley | Until Aug 18, 2026 · Past |
Log in to ask 6ix AI your own questions about BICO Group AB.